These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3021651)
41. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung. Harczy M; Maclouf J; Pradelles P; Braquet P; Borgeat P; Sirois P Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849 [TBL] [Abstract][Full Text] [Related]
42. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. Simon MF; Chap H; Braquet P; Douste-Blazy L Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518 [TBL] [Abstract][Full Text] [Related]
43. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. Dong JC; Li M; Wu GT Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):481-3, 502. PubMed ID: 10322836 [TBL] [Abstract][Full Text] [Related]
44. Further studies on the mechanism of action of leukotrienes and histamine on guinea pig lung parenchyma. Role of calcium, phospholipase and methyltransferase. Sirois P; Lauzière M; Braquet P Prostaglandins; 1986 Jun; 31(6):1117-33. PubMed ID: 3020616 [TBL] [Abstract][Full Text] [Related]
45. Role of cyclooxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4. Sirois P; Chagnon M; Borgeat P; Vallerand P Pharmacology; 1985; 31(4):225-36. PubMed ID: 2997811 [TBL] [Abstract][Full Text] [Related]
46. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M; Lefort J; Malanchère E; Vargaftig BB Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247 [TBL] [Abstract][Full Text] [Related]
47. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
48. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. Bourgain RH; Maes L; Braquet P; Andries R; Touqui L; Braquet M Prostaglandins; 1985 Aug; 30(2):185-97. PubMed ID: 3931178 [TBL] [Abstract][Full Text] [Related]
49. The contractile activities of lipoxin A4 and lipoxin B4 for guinea-pig airway tissues. Jacques CA; Spur BW; Crea AE; Lee TH Br J Pharmacol; 1988 Oct; 95(2):562-8. PubMed ID: 2852525 [TBL] [Abstract][Full Text] [Related]
50. Myotropic activity of leukotriene B4 on lung parenchyma strips is not necessarily attributable to thromboxane A2 release. Fitzpatrick FA; Lawson CF J Pharmacol Exp Ther; 1988 Jun; 245(3):839-44. PubMed ID: 2838607 [TBL] [Abstract][Full Text] [Related]
51. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB; Li CL; Lam MH; Shen TY Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370 [TBL] [Abstract][Full Text] [Related]
53. The action of leukotriene B4 (LTB4) on the lung. Sirois P; Borgeat P; Jeanson A; Roy S; Girard G Prostaglandins Med; 1980 Dec; 5(6):429-44. PubMed ID: 6258182 [TBL] [Abstract][Full Text] [Related]
54. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. Malo PE; Wasserman MA; Pfeiffer DF Prostaglandins; 1987 Feb; 33(2):209-25. PubMed ID: 3588971 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773 [TBL] [Abstract][Full Text] [Related]
56. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865 [TBL] [Abstract][Full Text] [Related]
57. Effect of PAF on selected smooth muscle preparations. Jancar S; Thériault P; Sirois P Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):157-60. PubMed ID: 2916079 [TBL] [Abstract][Full Text] [Related]
60. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. Pretolani M; Lefort J; Vargaftig BB Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]